Reform of the pricing system and evolution of the private medicines market in Morocco

##plugins.themes.academic_pro.article.sidebar##

Published Mar 10, 2026
https://doi.org/10.62438/tunismed.v104i01.6074
Download
PDF
Vol. 104 No. 01 (2026): Tunis Med Jan 2026

##plugins.themes.academic_pro.article.main##

Fatima Zahra Bimegdi
Laboratory of Pharmacology and Toxicology, Research Team in Pharmacoepidemiology and Pharmacoeconomics , Impasse Souissi,Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat 10100, Morocco
https://orcid.org/0009-0003-4578-4435
Abdelmajid Belaiche
Laboratory of Pharmacology and Toxicology, Research Team in Pharmacoepidemiology and Pharmacoeconomics , Impasse Souissi,Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat 10100, Morocco
Samir Ahid
Laboratory of Pharmacology and Toxicology, Research Team in Pharmacoepidemiology and Pharmacoeconomics , Impasse Souissi,Faculty of Medicine and Pharmacy, Mohammed V University in Rabat, Rabat 10100, Morocco

Abstract

Objective: The study shows the evolution of the market for medicines sold in pharmacies following the price revisions published by the Ministry of Health after the reform of the pricing system adopted in December 2013.


Methods: This is a retrospective study carried out following the crossing of lists of official price review bulletins published on the website of the General Secretariat of the Government and sales data for medicines between 2010 and 2018.


Results:Between 2010 and 2018, the total private market for generic and originator medicines recorded an average annual growth of +3% in volume and +3.7% in turnover. Between 2015 and 2018 and after the implementation of the reform,it rose from +1.1% to +3.9%. Once the price revisions were applied, the sales volume of generic medicines recorded an average annual growth of +3.5%, compared to +5.1% for their turnover (2015 and 2018). However, the sales volume of originator medicines recorded negative average annual growth (-0.7%). As for the segment of medicines affected by price reductions, between 2015 and 2018 it experienced negative average annual growth in volume (-0.8%), while its growth in turnover was positive (+3.3%).


Conclusion: Following the adoption of the terms of Decree 2-13-852 and the application of the revisions, the private medicines market has seen variable growth.

Keywords:

Private medicines market, price, decline, Morocco

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Beg S, Hasnain MS, Rahman M, Swain S. Chapter 1 - Introduction to Quality by Design (QbD): Fundamentals, Principles, and Applications. In: Beg S, Hasnain MS, éditeurs. Pharmaceutical Quality by Design [Internet]. Academic Press; 2019 [cité 25 déc 2024]. p. 1‑17. Disponible sur: https://www.sciencedirect.com/science/article/pii/B9780128157992000010
  2. Hafner T, Walkowiak H, Lee D, Aboagye-Nyame F. Defining pharmaceutical systems strengthening: concepts to enable measurement. Health Policy Plan. 1 mai 2017;32(4):572‑84.
  3. Vaguet A. L’espace politique des médicaments. L’Espace Politique Revue en ligne de géographie politique et de géopolitique [Internet]. 22 juill 2015 [cité 17 mars 2024];(26). Disponible sur: https://journals.openedition.org/espacepolitique/3534#tocto1n9
  4. Statista. Pharmaceutical market worldwide revenue 2001-2023. [Internet]. 2024 [cité 17 mars 2024]. Disponible sur: https://www.statista.com/statistics/263102/pharmaceutical-market-worldwide-revenue-since-2001/
  5. Direction de la Recherche, des Etudes, de l’Evaluation et des Statistiques. La consommation de médicaments dans les principaux pays industrialisés. [Internet]. 2000 janv. Disponible sur: https://drees.solidarites-sante.gouv.fr/sites/default/files/er047.pdf
  6. Le Haut Commissariat au Plan. Les indicateurs sociaux du Maroc [Internet]. 2023 Edition. Disponible sur: https://casainvest.ma/sites/default/files/Les%20indicateurs%20sociaux%20du%20Maroc%20HCP%202023.pdf
  7. Association Marocaine de l’Industrie Pharmaceutique. Le secteur pharmaceutique marocain: réalités sur les prix des médicaments et intérêt du secteur [Internet]. 2010. Disponible sur: https://pharmacie.ma/uploads/pdfs/amip_prix_medicament(1).pdf
  8. Conseil de la Concurrence. Avis du Conseil de la Concurrence A/4/20 relatif à la situation de la concurrence dans le marché du médicament au Maroc [Internet]. 2020 juin. Disponible sur: https://conseil-concurrence.ma/wp-content/uploads/2023/10/Avis-du-Conseil-de-la-Concurrence-Num-A.4.20-FR-du-15-01-21-Web_compressed.pdf
  9. Miglierini G. From Morocco: The opportunities for the pharmaceutical industry [Internet]. NCF International. 2018 [cité 16 juill 2024]. Disponible sur: https://www.ncfinternational.it/from-morocco-the-opportunities-for-the-pharmaceutical-industry/
  10. Conseil de la Concurrence. Etude sur la concurrentiabilité du secteur de l’industrie pharmaceutique [Internet]. 2011. Disponible sur: https://pharmacie.ma/uploads/pdfs/concurentiabilite(1).pdf
  11. Organisation Mondiale de la Santé. Enquête sur les Prix des Médicaments au Maroc [Internet]. 2004. Disponible sur: https://haiweb.org/wp-content/uploads/2015/07/Morocco-Report-Pricing-Surveys.pdf
  12. Chambre des Représentants. Commission des Finances. Mission d’information sur le prix du médicament. Rapport de la Mission d’Information sur le Prix du Médicament au Maroc [Internet]. 2009. Disponible sur: https://pharmacie.ma/uploads/pdfs/Rapport_de_mission_v41_0_Francais%281%29.pdf
  13. Secrétariat General du Gouvernement. Décret n°2-13-852 relatif aux conditions et aux modalités de fixation du prix public de Vente des Médicaments Fabriqués Localement ou Importés. déc, 2013.
  14. Saadeddine MA, Moujaddidi NE. L’industrie pharmaceutique et l’accès au soin au Maroc. Revue d’Etudes en Management et Finance d’Organisation [Internet]. 25 mars 2016 [cité 12 juill 2024];1(1). Disponible sur: https://revues.imist.ma/index.php/REMFO/article/view/4829
  15. Conseil Régional des pharmaciens d’officine du Sud. Etat des lieux des prix des médicaments et leur évolution entre 2014 et 2018 au Maroc. [Internet]. Conseil Régional des pharmaciens d’officine du Sud; 2019. Disponible sur: https://www.crpos.ma/pdf_site/etude_prix.pdf
  16. Les Entreprises du Médicament au Maroc. Les inspirations Eco du 24 Novembre 2017. [Internet]. 2017 [cité 24 avr 2025]. Disponible sur: https://www.lemm.ma/portfolio-item/les-generiques-dopent-le-marche/
  17. Pharmaceutical Executive. Country Report: Morocco. 2015 [cité 27 juill 2024]; Disponible sur: https://www.pharmexec.com/view/country-report-morocco
  18. IQVIA. Middle East & Africa Pharmaceutical Market Insights [Internet]. 2019. Disponible sur: https://www.iqvia.com/-/media/iqvia/pdfs/mea/edition-13-mea-pharmaceutical-market-quarterly-report.pdf
  19. Kamphuis BW, Kanavos P. Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. Health Policy OPEN [Internet]. 1 déc 2021 [cité 8 mai 2025];2:100045. Disponible sur: https://www.sciencedirect.com/science/article/pii/S2590229621000162
  20. Meng Q, Cheng G, Silver L, Sun X, Rehnberg C, Tomson G. The impact of China’s retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals. Health Policy and Planning [Internet]. 1 mai 2005 [cité 27 juill 2024];20(3):185‑96. Disponible sur: http://academic.oup.com/heapol/article/20/3/185/660349/The-impact-of-Chinas-retail-drug-price-control